FierceBiotech ١ أبريل ٢٠٢٦ Thousands of clinical trial sites impacted by Middle East conflict: report
FierceBiotech ١ أبريل ٢٠٢٦ Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech ١ أبريل ٢٠٢٦ ‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1
FierceBiotech ١ أبريل ٢٠٢٦ Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down
FierceBiotech ١ أبريل ٢٠٢٦ KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
FierceBiotech ٣١ مارس ٢٠٢٦ Iterum initiates wind-down after failure to offload antibiotic with sluggish sales
FierceBiotech ٣١ مارس ٢٠٢٦ Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play
FierceBiotech ٣١ مارس ٢٠٢٦ Obesity biotech Ambrosia scores $100M series B to take next-gen oral GLP-1 into the clinic
FierceBiotech ٣١ مارس ٢٠٢٦ AstraZeneca’s Strensiq successor misses phase 3 rare disease goal, denting market expansion plan
FierceBiotech ٣١ مارس ٢٠٢٦ Lipella files for bankruptcy, ending dream of developing mouth inflammation drug
FierceBiotech ٣٠ مارس ٢٠٢٦ Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community